NEFL and amyotrophic lateral sclerosis: ALS patients had higher NFL levels compared with healthy controls and patients with neurological complaints but no evidence of CNS pathology; serum NFL enabled discrimination between ALS and healthy controls with a sensitivity of 91.3% and a specificity of 91%.